<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2020-10-07" version="177">
<accession>Q9Y6H5</accession>
<accession>D3DSZ1</accession>
<accession>Q05BS1</accession>
<accession>Q1PSC2</accession>
<accession>Q49AC6</accession>
<accession>Q504U9</accession>
<accession>Q6L984</accession>
<accession>Q6L985</accession>
<accession>Q6L986</accession>
<accession>Q9HC59</accession>
<name>SNCAP_HUMAN</name>
<protein>
<recommendedName>
<fullName>Synphilin-1</fullName>
<shortName>Sph1</shortName>
</recommendedName>
<alternativeName>
<fullName>Alpha-synuclein-interacting protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SNCAIP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="110" last="114">
<title>Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.</title>
<authorList>
<person name="Engelender S."/>
<person name="Kaminsky Z."/>
<person name="Guo X."/>
<person name="Sharp A.H."/>
<person name="Amaravi R.K."/>
<person name="Kleiderlein J.J."/>
<person name="Margolis R.L."/>
<person name="Troncoso J.C."/>
<person name="Lanahan A."/>
<person name="Worley P.F."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="10319874"/>
<dbReference type="DOI" id="10.1038/8820"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH SNCA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT ALA-44</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mamm. Genome" volume="11" first="763" last="766">
<title>Organization of the human synphilin-1 gene, a candidate for Parkinson's disease.</title>
<authorList>
<person name="Engelender S."/>
<person name="Wanner T."/>
<person name="Kleiderlein J.J."/>
<person name="Wakabayashi K."/>
<person name="Tsuji S."/>
<person name="Takahashi H."/>
<person name="Ashworth R."/>
<person name="Margolis R.L."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="10967135"/>
<dbReference type="DOI" id="10.1007/s003350010123"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="5917" last="5922">
<title>Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients.</title>
<authorList>
<person name="Eyal A."/>
<person name="Szargel R."/>
<person name="Avraham E."/>
<person name="Liani E."/>
<person name="Haskin J."/>
<person name="Rott R."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="16595633"/>
<dbReference type="DOI" id="10.1073/pnas.0509707103"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SNCA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Identification and characterization of alternatively spliced form of human synphilin-1.</title>
<authorList>
<person name="Lim M.K."/>
<person name="Ohsawa Y."/>
<person name="Kawamura T."/>
<person name="Asakawa S."/>
<person name="Takayanagi A."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 4 AND 6)</scope>
<scope>VARIANT ALA-44</scope>
<source>
<tissue>Cerebellum</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 5)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Nat. Med." volume="7" first="1144" last="1150">
<title>Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.</title>
<authorList>
<person name="Chung K.K.K."/>
<person name="Zhang Y."/>
<person name="Lim K.L."/>
<person name="Tanaka Y."/>
<person name="Huang H."/>
<person name="Gao J."/>
<person name="Ross C.A."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
</authorList>
<dbReference type="PubMed" id="11590439"/>
<dbReference type="DOI" id="10.1038/nm1001-1144"/>
</citation>
<scope>INTERACTION WITH PRKN</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="29106" last="29114">
<title>Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1.</title>
<authorList>
<person name="Ito T."/>
<person name="Niwa J."/>
<person name="Hishikawa N."/>
<person name="Ishigaki S."/>
<person name="Doyu M."/>
<person name="Sobue G."/>
</authorList>
<dbReference type="PubMed" id="12750386"/>
<dbReference type="DOI" id="10.1074/jbc.m302763200"/>
</citation>
<scope>INTERACTION WITH RNF19A</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="51504" last="51514">
<title>Siah-1 facilitates ubiquitination and degradation of synphilin-1.</title>
<authorList>
<person name="Nagano Y."/>
<person name="Yamashita H."/>
<person name="Takahashi T."/>
<person name="Kishida S."/>
<person name="Nakamura T."/>
<person name="Iseki E."/>
<person name="Hattori N."/>
<person name="Mizuno Y."/>
<person name="Kikuchi A."/>
<person name="Matsumoto M."/>
</authorList>
<dbReference type="PubMed" id="14506261"/>
<dbReference type="DOI" id="10.1074/jbc.m306347200"/>
</citation>
<scope>INTERACTION WITH SIAH1</scope>
<scope>DEGRADATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="5500" last="5505">
<title>Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.</title>
<authorList>
<person name="Liani E."/>
<person name="Eyal A."/>
<person name="Avraham E."/>
<person name="Shemer R."/>
<person name="Szargel R."/>
<person name="Berg D."/>
<person name="Bornemann A."/>
<person name="Riess O."/>
<person name="Ross C.A."/>
<person name="Rott R."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="15064394"/>
<dbReference type="DOI" id="10.1073/pnas.0401081101"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
<scope>INTERACTION WITH SIAH1 AND SIAH2</scope>
<scope>MUTAGENESIS OF VAL-79 AND PRO-81</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="11706" last="11716">
<title>Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.</title>
<authorList>
<person name="Szargel R."/>
<person name="Rott R."/>
<person name="Eyal A."/>
<person name="Haskin J."/>
<person name="Shani V."/>
<person name="Balan L."/>
<person name="Wolosker H."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="19224863"/>
<dbReference type="DOI" id="10.1074/jbc.m805990200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SIAH1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="FASEB J." volume="24" first="196" last="205">
<title>Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication.</title>
<authorList>
<person name="Xie Y.Y."/>
<person name="Zhou C.J."/>
<person name="Zhou Z.R."/>
<person name="Hong J."/>
<person name="Che M.X."/>
<person name="Fu Q.S."/>
<person name="Song A.X."/>
<person name="Lin D.H."/>
<person name="Hu H.Y."/>
</authorList>
<dbReference type="PubMed" id="19762560"/>
<dbReference type="DOI" id="10.1096/fj.09-133082"/>
</citation>
<scope>STRUCTURE BY NMR OF 512-557</scope>
<scope>INTERACTION WITH SNCA</scope>
<scope>PROMOTION OF INCLUSION BODY FORMATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="1223" last="1231">
<title>Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.</title>
<authorList>
<person name="Marx F.P."/>
<person name="Holzmann C."/>
<person name="Strauss K.M."/>
<person name="Li L."/>
<person name="Eberhardt O."/>
<person name="Gerhardt E."/>
<person name="Cookson M.R."/>
<person name="Hernandez D."/>
<person name="Farrer M.J."/>
<person name="Kachergus J."/>
<person name="Engelender S."/>
<person name="Ross C.A."/>
<person name="Berger K."/>
<person name="Schols L."/>
<person name="Schulz J.B."/>
<person name="Riess O."/>
<person name="Kruger R."/>
</authorList>
<dbReference type="PubMed" id="12761037"/>
<dbReference type="DOI" id="10.1093/hmg/ddg134"/>
</citation>
<scope>VARIANT CYS-621</scope>
<scope>CHARACTERIZATION OF VARIANT CYS-621</scope>
<scope>POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO PARKINSON DISEASE</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="BMC Med. Genet." volume="9" first="19" last="19">
<title>Genetic association study of synphilin-1 in idiopathic Parkinson's disease.</title>
<authorList>
<person name="Myhre R."/>
<person name="Klungland H."/>
<person name="Farrer M.J."/>
<person name="Aasly J.O."/>
</authorList>
<dbReference type="PubMed" id="18366718"/>
<dbReference type="DOI" id="10.1186/1471-2350-9-19"/>
</citation>
<scope>VARIANTS ALA-44; CYS-621 AND GLN-706</scope>
<scope>LACK OF ASSOCIATION WITH PARKINSON DISEASE</scope>
</reference>
<comment type="function">
<text evidence="9 11">Isoform 2 inhibits the ubiquitin ligase activity of SIAH1 and inhibits proteasomal degradation of target proteins. Isoform 2 inhibits autoubiquitination and proteasomal degradation of SIAH1, and thereby increases cellular levels of SIAH. Isoform 2 modulates SNCA monoubiquitination by SIAH1.</text>
</comment>
<comment type="subunit">
<text evidence="3 4 5 7 8 9 11 12 17">Homodimer (Probable). Heterodimer of isoform 1 and isoform 2 (Probable). Interacts with SIAH1, SIAH2, SNCA, RNF19A AND PRKN. Isoform 2 has a strong tendency to form aggregates and can sequester isoform 1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-717182">
<id>Q9Y6H5</id>
</interactant>
<interactant intactId="EBI-985879">
<id>P37840</id>
<label>SNCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-717182">
<id>Q9Y6H5</id>
</interactant>
<interactant intactId="EBI-717182">
<id>Q9Y6H5</id>
<label>SNCAIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9075374">
<id>Q9Y6H5-1</id>
</interactant>
<interactant intactId="EBI-9075360">
<id>O60229-2</id>
<label>KALRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15577909">
<id>Q9Y6H5-2</id>
</interactant>
<interactant intactId="EBI-985879">
<id>P37840</id>
<label>SNCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3 8 9 12">Cytoplasm</location>
</subcellularLocation>
<text>Detected in cytoplasmic inclusion bodies, together with SNCA.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y6H5-1</id>
<name>1</name>
<name>1a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y6H5-2</id>
<name>2</name>
<name>Synphilin-1A</name>
<sequence type="described" ref="VSP_038839 VSP_038842 VSP_038845"/>
</isoform>
<isoform>
<id>Q9Y6H5-3</id>
<name>3</name>
<sequence type="described" ref="VSP_038840 VSP_038845"/>
</isoform>
<isoform>
<id>Q9Y6H5-4</id>
<name>4</name>
<name>1b</name>
<sequence type="described" ref="VSP_038841"/>
</isoform>
<isoform>
<id>Q9Y6H5-5</id>
<name>5</name>
<sequence type="described" ref="VSP_038839 VSP_038842"/>
</isoform>
<isoform>
<id>Q9Y6H5-6</id>
<name>6</name>
<name>1c</name>
<sequence type="described" ref="VSP_038840 VSP_038843 VSP_038844"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="3 9">Detected in brain (at protein level). Widely expressed, with highest levels in brain, heart and placenta.</text>
</comment>
<comment type="PTM">
<text evidence="4 5 8">Ubiquitinated; mediated by SIAH1, SIAH2 or RNF19A and leading to its subsequent proteasomal degradation. In the absence of proteasomal degradation, ubiquitinated SNCAIP accumulates in cytoplasmic inclusion bodies. Isoform 2 is subject to limited ubiquitination that does not lead to proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="6">
<disease id="DI-02134">
<name>Parkinson disease</name>
<acronym>PARK</acronym>
<description>A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.</description>
<dbReference type="MIM" id="168600"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Constructs encoding portions of SNCA and SNCAIP co-transfected in mammalian cells promote cytosolic inclusions resembling the Lewy bodies of Parkinson disease. Coexpression of SNCA, SNCAIP, and PRKN result in the formation of Lewy body-like. ubiquitin-positive cytosolic inclusions. SNCAIP isoform 2 is particularly aggregation-prone. Familial mutations in PRKN disrupt the ubiquitination of SNCAIP and the formation of the ubiquitin-positive inclusions. These results provide a molecular basis for the ubiquitination of Lewy body-associated proteins and link PRKN and SNCA in a common pathogenic mechanism through their interaction with SNCAIP.</text>
</comment>
<dbReference type="EMBL" id="AF076929">
<property type="protein sequence ID" value="AAD30362.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167306">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167301">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167302">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167303">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167304">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167305">
<property type="protein sequence ID" value="AAG17478.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ227317">
<property type="protein sequence ID" value="ABB51162.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471086">
<property type="protein sequence ID" value="EAW48889.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB110788">
<property type="protein sequence ID" value="BAD19017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB110789">
<property type="protein sequence ID" value="BAD19018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB110790">
<property type="protein sequence ID" value="BAD19019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471086">
<property type="protein sequence ID" value="EAW48890.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033743">
<property type="protein sequence ID" value="AAH33743.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040552">
<property type="protein sequence ID" value="AAH40552.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC094759">
<property type="protein sequence ID" value="AAH94759.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4131.1">
<molecule id="Q9Y6H5-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58964.1">
<molecule id="Q9Y6H5-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS78054.1">
<molecule id="Q9Y6H5-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001229864.1">
<molecule id="Q9Y6H5-2"/>
<property type="nucleotide sequence ID" value="NM_001242935.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295029.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="NM_001308100.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295034.1">
<molecule id="Q9Y6H5-4"/>
<property type="nucleotide sequence ID" value="NM_001308105.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295035.1">
<property type="nucleotide sequence ID" value="NM_001308106.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295036.1">
<molecule id="Q9Y6H5-5"/>
<property type="nucleotide sequence ID" value="NM_001308107.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295037.1">
<property type="nucleotide sequence ID" value="NM_001308108.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295038.1">
<property type="nucleotide sequence ID" value="NM_001308109.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005451.2">
<molecule id="Q9Y6H5-1"/>
<property type="nucleotide sequence ID" value="NM_005460.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542039.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543737.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542040.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543738.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542041.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543739.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542043.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543741.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542045.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_011543743.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016865567.1">
<molecule id="Q9Y6H5-3"/>
<property type="nucleotide sequence ID" value="XM_017010078.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016865571.1">
<molecule id="Q9Y6H5-1"/>
<property type="nucleotide sequence ID" value="XM_017010082.1"/>
</dbReference>
<dbReference type="PDB" id="2KES">
<property type="method" value="NMR"/>
<property type="chains" value="A=512-557"/>
</dbReference>
<dbReference type="PDBsum" id="2KES"/>
<dbReference type="BMRB" id="Q9Y6H5"/>
<dbReference type="SMR" id="Q9Y6H5"/>
<dbReference type="BioGRID" id="114986">
<property type="interactions" value="35"/>
</dbReference>
<dbReference type="CORUM" id="Q9Y6H5"/>
<dbReference type="DIP" id="DIP-61155N"/>
<dbReference type="IntAct" id="Q9Y6H5">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="Q9Y6H5"/>
<dbReference type="STRING" id="9606.ENSP00000261368"/>
<dbReference type="ChEMBL" id="CHEMBL1926494"/>
<dbReference type="iPTMnet" id="Q9Y6H5"/>
<dbReference type="PhosphoSitePlus" id="Q9Y6H5"/>
<dbReference type="BioMuta" id="SNCAIP"/>
<dbReference type="DMDM" id="205831000"/>
<dbReference type="EPD" id="Q9Y6H5"/>
<dbReference type="jPOST" id="Q9Y6H5"/>
<dbReference type="MassIVE" id="Q9Y6H5"/>
<dbReference type="PaxDb" id="Q9Y6H5"/>
<dbReference type="PeptideAtlas" id="Q9Y6H5"/>
<dbReference type="PRIDE" id="Q9Y6H5"/>
<dbReference type="ProteomicsDB" id="86680">
<molecule id="Q9Y6H5-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86681">
<molecule id="Q9Y6H5-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86682">
<molecule id="Q9Y6H5-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86683">
<molecule id="Q9Y6H5-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86684">
<molecule id="Q9Y6H5-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86685">
<molecule id="Q9Y6H5-6"/>
</dbReference>
<dbReference type="Antibodypedia" id="1015">
<property type="antibodies" value="215 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000261367">
<molecule id="Q9Y6H5-3"/>
<property type="protein sequence ID" value="ENSP00000261367"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000261368">
<molecule id="Q9Y6H5-1"/>
<property type="protein sequence ID" value="ENSP00000261368"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000379538">
<molecule id="Q9Y6H5-2"/>
<property type="protein sequence ID" value="ENSP00000368854"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395469">
<molecule id="Q9Y6H5-6"/>
<property type="protein sequence ID" value="ENSP00000378852"/>
<property type="gene ID" value="ENSG00000064692"/>
</dbReference>
<dbReference type="GeneID" id="9627"/>
<dbReference type="KEGG" id="hsa:9627"/>
<dbReference type="UCSC" id="uc003ksw.2">
<molecule id="Q9Y6H5-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9627"/>
<dbReference type="DisGeNET" id="9627"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000064692.18"/>
<dbReference type="GeneCards" id="SNCAIP"/>
<dbReference type="HGNC" id="HGNC:11139">
<property type="gene designation" value="SNCAIP"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000064692">
<property type="expression patterns" value="Tissue enhanced (endometrium, ovary)"/>
</dbReference>
<dbReference type="MalaCards" id="SNCAIP"/>
<dbReference type="MIM" id="168600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603779">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y6H5"/>
<dbReference type="OpenTargets" id="ENSG00000064692"/>
<dbReference type="PharmGKB" id="PA35987"/>
<dbReference type="eggNOG" id="KOG0504">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000001485"/>
<dbReference type="HOGENOM" id="CLU_012404_0_0_1"/>
<dbReference type="InParanoid" id="Q9Y6H5"/>
<dbReference type="KO" id="K04558"/>
<dbReference type="OMA" id="QGHADCL"/>
<dbReference type="OrthoDB" id="167171at2759"/>
<dbReference type="PhylomeDB" id="Q9Y6H5"/>
<dbReference type="TreeFam" id="TF329095"/>
<dbReference type="PathwayCommons" id="Q9Y6H5"/>
<dbReference type="Reactome" id="R-HSA-977225">
<molecule id="Q9Y6H5-2"/>
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9Y6H5"/>
<dbReference type="BioGRID-ORCS" id="9627">
<property type="hits" value="4 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SNCAIP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9Y6H5"/>
<dbReference type="GeneWiki" id="SNCAIP"/>
<dbReference type="GenomeRNAi" id="9627"/>
<dbReference type="Pharos" id="Q9Y6H5">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Y6H5"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q9Y6H5">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000064692">
<property type="expression patterns" value="Expressed in ventricular zone and 213 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9Y6H5">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y6H5">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0036464">
<property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042734">
<property type="term" value="C:presynaptic membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008021">
<property type="term" value="C:synaptic vesicle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008219">
<property type="term" value="P:cell death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042417">
<property type="term" value="P:dopamine metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0090083">
<property type="term" value="P:regulation of inclusion body assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046928">
<property type="term" value="P:regulation of neurotransmitter secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002110">
<property type="entry name" value="Ankyrin_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR020683">
<property type="entry name" value="Ankyrin_rpt-contain_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036770">
<property type="entry name" value="Ankyrin_rpt-contain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR040133">
<property type="entry name" value="SNCAIP"/>
</dbReference>
<dbReference type="InterPro" id="IPR032027">
<property type="entry name" value="SNCAIP_SNCA-bd"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR22882">
<property type="entry name" value="PTHR22882"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12796">
<property type="entry name" value="Ank_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF16700">
<property type="entry name" value="SNCAIP_SNCA_bd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00248">
<property type="entry name" value="ANK"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48403">
<property type="entry name" value="SSF48403"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50297">
<property type="entry name" value="ANK_REP_REGION"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50088">
<property type="entry name" value="ANK_REPEAT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0040">ANK repeat</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0907">Parkinson disease</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Synphilin-1" id="PRO_0000067068">
<location>
<begin position="1"/>
<end position="919"/>
</location>
</feature>
<feature type="repeat" description="ANK 1">
<location>
<begin position="349"/>
<end position="380"/>
</location>
</feature>
<feature type="repeat" description="ANK 2">
<location>
<begin position="384"/>
<end position="413"/>
</location>
</feature>
<feature type="repeat" description="ANK 3">
<location>
<begin position="419"/>
<end position="448"/>
</location>
</feature>
<feature type="repeat" description="ANK 4">
<location>
<begin position="456"/>
<end position="485"/>
</location>
</feature>
<feature type="repeat" description="ANK 5">
<location>
<begin position="603"/>
<end position="632"/>
</location>
</feature>
<feature type="repeat" description="ANK 6">
<location>
<begin position="699"/>
<end position="729"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="2">
<location>
<begin position="515"/>
<end position="552"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 5." id="VSP_038839" evidence="14 15">
<location>
<begin position="1"/>
<end position="366"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 6." id="VSP_038840" evidence="14 16">
<original>S</original>
<variation>SDNRSQGNRLQKLGLEDTDREDAMGFGSHRAKLTVVAALGACHCPENE</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_038841" evidence="16">
<location>
<begin position="335"/>
<end position="394"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 5." id="VSP_038842" evidence="14 15">
<original>QHLTSLMGEDCLNERNTEKLTPAGLAIK</original>
<variation>MTYLIQSHHSRRSQNCAEDVIRKTKTDQ</variation>
<location>
<begin position="367"/>
<end position="394"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_038843" evidence="16">
<original>LVEYGANVTMQNHAGEKPSQSAERQGHTLCSRYLVVVETCMSLASQVVKLTKQLKEQTVERVTLQN</original>
<variation>RLKIQGTWNGSETCLFTHHFSSYPPISSGLQCQGQEGVLFIPDQVGAATNKQVLFQNQLPETKSSY</variation>
<location>
<begin position="476"/>
<end position="541"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_038844" evidence="16">
<location>
<begin position="542"/>
<end position="919"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_038845" evidence="14 15">
<original>A</original>
<variation>EMYSSCINLSSNMLIEEHLCNDTRHNDINRKMKKSYSIKHIAEPESKELFL</variation>
<location>
<position position="919"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56285021." id="VAR_065358" evidence="3 10 13">
<original>V</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6867105." id="VAR_048312">
<original>E</original>
<variation>G</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with symptoms of Parkinson disease; unknown pathological significance; reduced number of cytoplasmic inclusions in cells expressing C-621 compared with cells expressing wild-type (wt) protein when subjected to proteasomal inhibition; C-621 transfected cells are more susceptible to staurosporine-induced cell death than cells expressing wt protein; dbSNP:rs28937592." id="VAR_025667" evidence="6 10">
<original>R</original>
<variation>C</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_065359" evidence="10">
<original>E</original>
<variation>Q</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with SIAH1 and formation of cytoplasmic inclusion bodies; when associated with N-81." evidence="8">
<original>V</original>
<variation>N</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with SIAH1 and formation of cytoplasmic inclusion bodies; when associated with N-79." evidence="8">
<original>P</original>
<variation>N</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH40552." ref="6" evidence="17">
<original>S</original>
<variation>F</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH40552." ref="6" evidence="17">
<original>E</original>
<variation>G</variation>
<location>
<position position="614"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH40552." ref="6" evidence="17">
<original>A</original>
<variation>G</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH94759." ref="6" evidence="17">
<original>D</original>
<variation>G</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH33743." ref="6" evidence="17">
<original>S</original>
<variation>P</variation>
<location>
<position position="801"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH94759." ref="6" evidence="17">
<original>A</original>
<variation>E</variation>
<location>
<position position="919"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="512"/>
<end position="554"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KES"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10319874"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11590439"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750386"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12761037"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14506261"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15064394"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16595633"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18366718"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19224863"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19762560"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16595633"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="919" mass="100409" checksum="55C5316F250D0480" modified="2008-07-22" version="2">MEAPEYLDLDEIDFSDDISYSVTSLKTIPELCRRCDTQNEDRSVSSSSWNCGISTLITNTQKPTGIADVYSKFRPVKRVSPLKHQPETLENNESDDQKNQKVVEYQKGGESDLGPQPQELGPGDGVGGPPGKSSEPSTSLGELEHYDLDMDEILDVPYIKSSQQLASFTKVTSEKRILGLCTTINGLSGKACSTGSSESSSSNMAPFCVLSPVKSPHLRKASAVIHDQHKLSTEETEISPPLVKCGSAYEPENQSKDFLNKTFSDPHGRKVEKTTPDCQLRAFHLQSSAAESKPEEQVSGLNRTSSQGPEERSEYLKKVKSILNIVKEGQISLLPHLAADNLDKIHDENGNNLLHIAASQGHAECLQHLTSLMGEDCLNERNTEKLTPAGLAIKNGQLECVRWMVSETEAIAELSCSKDFPSLIHYAGCYGQEKILLWLLQFMQEQGISLDEVDQDGNSAVHVASQHGYLGCIQTLVEYGANVTMQNHAGEKPSQSAERQGHTLCSRYLVVVETCMSLASQVVKLTKQLKEQTVERVTLQNQLQQFLEAQKSEGKSLPSSPSSPSSPASRKSQWKSPDADDDSVAKSKPGVQEGIQVLGSLSASSRARPKAKDEDSDKILRQLLGKEISENVCTQEKLSLEFQDAQASSRNSKKIPLEKRELKLARLRQLMQRSLSESDTDSNNSEDPKTTPVRKADRPRPQPIVESVESMDSAESLHLMIKKHTLASGGRRFPFSIKASKSLDGHSPSPTSESSEPDLESQYPGSGSIPPNQPSGDPQQPSPDSTAAQKVATSPKSALKSPSSKRRTSQNLKLRVTFEEPVVQMEQPSLELNGEKDKDKGRTLQRTSTSNESGDQLKRPFGAFRSIMETLSGNQNNNNNYQAANQLKTSTLPLTSLGRKTDAKGNPASSASKGKNKAA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

